Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q905058> ?p ?o }
Showing triples 1 to 51 of
51
with 100 triples per page.
- Q905058 subject Q18706655.
- Q905058 subject Q7158322.
- Q905058 subject Q8388304.
- Q905058 subject Q8971959.
- Q905058 subject Q9062040.
- Q905058 subject Q9546190.
- Q905058 abstract "Mesocarb (brand names Sidnocarb, Sydnocarb) is a stimulant drug which was developed in the USSR in the 1970s. It has been found to act as a selective dopamine reuptake inhibitor, and is less potent and slower acting but longer lasting than dextroamphetamine.Mesocarb was used for a variety of applications; these include counteracting the sedative effects of benzodiazepine drugs, increasing workload capacity and cardiovascular function, treatment of ADHD and hyperactivity in children, as a nootropic, and as a drug to enhance resistance to extremely cold temperatures. It is also listed as having antidepressant and anticonvulsant properties.Mesocarb was sold in Russia as 5 milligram tablets under the brand name Sydnocarb. Hydroxylated metabolites can be detected in urine for up to 10 days after consumption.Mesocarb is almost unknown in the western world and is neither used in medicine or studied scientifically to any great extent outside Russia and other countries in the former Soviet Union. It has however been added to the list of drugs under international control and is illegal in most countries, despite its multiple therapeutic applications and reported lack of significant abuse potential.Mesocarb has been referred to as a prodrug of amphetamine. Indeed, it produces amphetamine as a metabolite, and amphetamine concentrations are far higher than mesocarb concentrations in human urine 22 hours post-administration (0.7–186 ng/mL and 0.004–0.17 ng/mL, respectively). However, mesocarb also possesses molecular actions of its own, inhibiting the reuptake of dopamine and to a far lesser extent of norepinephrine, but not of serotonin.".
- Q905058 atcPrefix "none".
- Q905058 casNumber "34262-84-5".
- Q905058 fdaUniiCode "UMT8MP2NDU".
- Q905058 iupacName "5-(Phenylcarbamoylimino)-3-(1-phenylpropan-2-yl)-5H-1,2,3-oxadiazol-3-ium-2-ide".
- Q905058 pubchem "71932".
- Q905058 thumbnail Sidnocarb.svg?width=300.
- Q905058 wikiPageWikiLink Q15180.
- Q905058 wikiPageWikiLink Q159.
- Q905058 wikiPageWikiLink Q167934.
- Q905058 wikiPageWikiLink Q1706418.
- Q905058 wikiPageWikiLink Q179452.
- Q905058 wikiPageWikiLink Q181923.
- Q905058 wikiPageWikiLink Q186242.
- Q905058 wikiPageWikiLink Q18706655.
- Q905058 wikiPageWikiLink Q211036.
- Q905058 wikiPageWikiLink Q3184856.
- Q905058 wikiPageWikiLink Q407595.
- Q905058 wikiPageWikiLink Q576618.
- Q905058 wikiPageWikiLink Q603741.
- Q905058 wikiPageWikiLink Q6821509.
- Q905058 wikiPageWikiLink Q7158322.
- Q905058 wikiPageWikiLink Q742487.
- Q905058 wikiPageWikiLink Q76560.
- Q905058 wikiPageWikiLink Q7660250.
- Q905058 wikiPageWikiLink Q8386.
- Q905058 wikiPageWikiLink Q83871.
- Q905058 wikiPageWikiLink Q8388304.
- Q905058 wikiPageWikiLink Q8971959.
- Q905058 wikiPageWikiLink Q899647.
- Q905058 wikiPageWikiLink Q9062040.
- Q905058 wikiPageWikiLink Q9546190.
- Q905058 atcPrefix "none".
- Q905058 casNumber "34262".
- Q905058 iupacName "5".
- Q905058 pubchem "71932".
- Q905058 unii "UMT8MP2NDU".
- Q905058 type ChemicalSubstance.
- Q905058 type Drug.
- Q905058 type ChemicalObject.
- Q905058 type Thing.
- Q905058 type Q8386.
- Q905058 comment "Mesocarb (brand names Sidnocarb, Sydnocarb) is a stimulant drug which was developed in the USSR in the 1970s.".
- Q905058 label "Mesocarb".
- Q905058 depiction Sidnocarb.svg.